Explore › Condition › HIV
Condition

HIV

Also known as: AIDS Virus AIDS Viruses AIDS virus Acquired Immune Deficiency Syndrome Virus Acquired Immunodeficiency Syndrome Virus HIV HIV - Human immunodeficiency virus HIV; accelerated nicotine metabolism HIV; heavier cigarette smoking HIV; neural tube defects HTLV-III HUMAN IMMUNODEFIC VIRUS +31 more
18 findings 2 papers 15 related entities View in graph →

Related entities

interventions
dolutegravir exposure2 non-dolutegravir antiretroviral drug exposure2 Efavirenz-based antiretroviral therapy1 nicotine metabolism1
outcomes
High risk pregnancy due to recurrent pregnancy loss2 Increase or decrease in folic acid content of the diet. Prevention of megaloblastic anemia and risk of neural tube defects in the newborn. (Source: Office of Dietary Supplments National Institutes of Health. Dietary Supplement Fact Sheet: Folate)1 Stillbirth1 Nicotine metabolite ratio1 Cigarettes per day1
populations
Pregnant Women2 Women2 HIV-positive Patients1 HIV-positive smokers1
studys
PMC106140304 PMC63312372

Findings (50)

None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with smoking more cigarettes per day among HIV-positive smokers, replicating the well-established NMR-smoking rate relationship in the gen

Effect: decline; r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multivariate)

Size: r = .30, p = .001 (univariate); b = 0.188, p = 0.050 (multiv
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →
None
decline

HIV-positive smokers taking efavirenz had significantly faster nicotine metabolism (higher NMR) than those not taking efavirenz in a multiple regression model, with efavirenz alone accounting for 5% u

Effect: decline; b = 0.221, p = .010

Size: b = 0.221, p = .010
PMC6331237
Finding details → · Paper → · Graph →

Papers (2)